我省药品全生命周期智慧管理水平显著提升

Core Insights - The provincial drug regulatory authority is advancing smart regulation through information technology, aiming to enhance regulatory efficiency and quality during the 14th Five-Year Plan period [2][3] Group 1: Smart Regulation Framework - The authority emphasizes a unified approach to smart regulation across the province, adopting a centralized construction model to ensure system interconnectivity and data sharing, thereby avoiding information silos [2] - A comprehensive smart regulation platform is being developed with a "123+X" architecture, which includes one drug regulatory data center, two portals, three support systems, and several key applications [2] Group 2: Information System Development - The province is focusing on the coordinated development of regulatory information systems to create practical and user-friendly digital platforms [3] - An online service hall has been established for drug licensing and filing, enabling a "one-stop" online process for application, approval, technical review, and feedback [3] - A comprehensive drug regulatory system has been launched to facilitate real-time data collection and entry for inspections, administrative penalties, and sampling, enhancing cross-regional regulatory collaboration [3] Group 3: Data-Driven Regulation - A provincial drug regulatory data center is being built to consolidate various regulatory data, including licensing, inspections, and complaints, to support data governance and public access [3] - The establishment of drug safety credit files and product archives will allow for risk warning analysis and scientific regulation, ensuring transparency in drug regulation [3] Group 4: Traditional Chinese Medicine (TCM) Initiatives - The province has pioneered an information traceability platform for TCM pieces, collecting traceability data to connect the production, circulation, and regulatory chains, contributing over 20 replicable results [4] - This platform has been recognized as a model project by the National Medical Products Administration, showcasing the province's experience in TCM traceability [4] Group 5: Future Directions - The provincial drug regulatory authority plans to leverage new technologies such as artificial intelligence, big data, and machine vision to accelerate the digital transformation of drug regulation [4] - The goal is to transition from "machine assistance" to "intelligent operations," enhancing the convenience of government services, efficiency of data governance, and robustness of the traceability system [4]